TNF-α inhibits glucocorticoid receptor-induced gene expression by reshaping the GR nuclear cofactor profile

Karen Dendoncker,Steven Timmermans,Jolien Vandewalle,Melanie Eggermont,Joanna Lempiäinen,Ville Paakinaho,Evelien Van Hamme,Sylviane Dewaele,Sofie Vandevyver,Marlies Ballegeer,Jolien Souffriau,Lise Van Wyngene,Kelly Van Looveren,Tineke Vanderhaeghen,Rudi Beyaert,Karolien De Bosscher,Marc Van Montagu,Claude Libert,Jorma J. Palvimo
DOI: https://doi.org/10.1073/pnas.1821565116
IF: 11.1
2019-06-10
Proceedings of the National Academy of Sciences
Abstract:Significance Millions of patients suffer from inflammatory diseases and are treated by synthetic glucocorticoids as a first-line medication, but many become resistant after a certain period or display a lack of response to the treatment. The inflammatory cytokine TNF has been shown to be an important inducer of glucocorticoid resistance (GCR) against the antiinflammatory effects of glucocorticoids. We found an aspect of the GCR mechanism that specifically involves the sequestration of a transcriptional cofactor p300 by the inflammatory transcription factor NFκB, precluding accessibility to the glucocorticoid receptor (GR). Our data suggest that selective increase of the p300 availability for GR, but not for NFκB, may prevent or revert the problem of GCR and improve the glucocorticoid therapeutic value in inflammation.
What problem does this paper attempt to address?